Ipsen

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. At a time when markets are more volatile than at any point since the 2008 financial crisis, it’s critically important for company...

Baird believes Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is taking steps in the right direction by announcing the sale of its metastatic pancreatic cancer drug Onivyde to French drug maker Ipsen and refocusing on its pipeline assets. The sale comes after Merrimack announcement in December to...